MiMedx Group Investor Relations Material
Latest events
Q2 2024
MiMedx Group
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from MiMedx Group Inc
Access all reports
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. MiMedx's products comprise placenta tissue allografts, umbilical cord blood allografts, amniotic membranes and amniotic allografts. The Company’s placental tissue pacification system which is the world’s first non-hormonal device (Harmony), comprises a combination of devices that are temporarily implanted into a patient to help restore normal hormonal and endocrine levels in women who have undergone a hysterectomy or oophorectomy due to cancer. Other products sold by MiMedx include a range of tissue conditioners, skin substitutes and hyaluronic acid gel products.
Key slides for MiMedx Group Inc
Investor Presentation
MiMedx Group Inc
Investor Presentation
MiMedx Group Inc
Latest articles
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
MDXG
Country
🇺🇸 United States